ABT

2024Q2BMO

Abbott Laboratories primary · HEALTHCARE · MEDICAL DEVICES

Report 2024-07-18 · Fiscal end 2024-06-30 · Features as of 2024-07-17

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS1.10
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move4.0%
IV front—
P/C full—
P/C front—
Features as of2024-07-17

Run-up

Close—
Ret 5d+1.6%
Ret 10d+1.4%
Ret 20d+1.2%
Ret 30d+1.8%

Post-Earnings Data

Results & reaction

Print

Actual EPS
1.14Beat
Estimated EPS1.10
Actual revenue
10.4B
Surprise %+3.6%
Beat / missBeat
Beat streak 42
Beat streak 82

Reaction

1-day stock reaction-2.3%
Implied vs actual

Implied 4.0%Actual 2.2%

Gap reaction-2.2%
Day result-4.4%
Next-day upNo
Realized / IV0.55×

Post tape

Post 5d+5.9%
Post 10d+10.1%
Post volume13.1M
Vol ×10d2.13×
Vol ×20d2.16×
Post range4.3%